Navigation Links
Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
Date:9/23/2010

ROANOKE, Va., Sept. 23 /PRNewswire-USNewswire/ -- The Society of Pharmaceutical and Biotech Trainers (SPBT) today announced that Kevin Kruse has been named the new executive director, effective October 1.  He brings to his new role significant life science training experience and strong entrepreneurial expertise.  

Mr. Kruse will be responsible for leading the operations and educational services of SPBT, a non-profit organization that represents more than 1,000 members in the training profession from pharmaceutical, biotech, medical device and diagnostic companies.  For the last 20 years, Mr. Kruse has dedicated his career to determining the most effective ways to design and deliver health-related education and training.

"Kevin is an experienced and passionate advocate for the training industry and he understands the impact that our organization has on the profession as well as the individual careers of our members," said SPBT Board President Mike Capaldi.  "Kevin has an impressive portfolio of training expertise and we are pleased to have his leadership at SPBT."

Mr. Kruse is the founder of several life science training and communication companies including ACI, Kenexa and AXIOM. Most recently, he served as founder and president of KRU Research, a media-consultancy serving life science marketers and healthcare educators. His organizations have been recognized with numerous awards including Inc 500 and Best Place to Work in Pennsylvania.  Mr. Kruse has also been named one of the "Top 100 Most Inspiring People in the Life Science Industry" by PharmaVoice.  He has written or contributed to numerous books including: Technology-based Training: The Art and Science of Design, Development, and Delivery; What Smart Trainers Know; Active Training; and We: Driving Full Engagement for Performance and Profits.

Mr. Kruse succeeds Brian Fagan, who has announced his retirement after serving as executive director for 13 years.

ABOUT SPBT

The Society of Pharmaceutical and Biotech Trainers (SPBT) is a worldwide 501©3 nonprofit organization dedicated to supporting trainers at pharmaceutical, biotech, medical device, and diagnostic companies. SPBT provides resources to help trainers excel, personally and professionally. The organization also aims to reinforce the valuable contributions that trainers bring to their companies.

SPBT was established in 1971 and originally named the National Society of Pharmaceutical Sales Trainers. Today, SPBT has a membership of more than 1,000 trainers employed by over 240 pharmaceutical, biotech, medical device, and diagnostic companies around the globe.


'/>"/>
SOURCE Society of Pharmaceutical and Biotech Trainers
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Sanford Rose Associates(R)-Rochester Named Top Office
3. Novo Nordisk Named a 2010 Working Mother 100 Best Company
4. AlloSource Named One of Colorados Top Three Healthcare Companies
5. Medicago named in Presidential report on meeting the challenges of pandemic influenza
6. maxIT Healthcare Named to Inc. 5000 List
7. BioPharm Systems Named to the 2010 Inc. 500
8. 5000 List of Fastest-Growing Companies in the U.S.
9. Bill Gates Named Keynote Speaker at the 2010 mHealth Summit
10. NeoStem Named Best Stem Cell Company in The New Economys 2010 Biotech Awards
11. Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... LAKE, N.J. , Dec. 5, 2016 /PRNewswire/ ... Phase 3 open-label two-year study of rufinamide, which ... the American Epilepsy Society (AES) held from December ... Analysis of final two-year safety, tolerability and cognitive ... with rufinamide experienced similar safety and tolerability profiles, ...
(Date:12/4/2016)... -- In five studies being presented today during the 58th ... in San Diego , researchers are ... of life-saving treatments to patients with a variety of ... therapies directly to the sites in the body where ... advantage over traditional, systemic methods. The studies highlight the ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
(Date:12/2/2016)... ... December 01, 2016 , ... Aerocom Healthcare ( http://www.aerocomhealthcare.com ... will present its chain-of-custody solution for tracking and securing medications at booth 676 ... 4-8, 2016. , Aerocom has a proven solution for tracking medications via its ...
Breaking Biology Technology:
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):